Lamar Smith bought Biomarin Pharmaceutical Inc (NASDAQ: BMRN)
Lamar Smith (R-TX), a U.S. Representative, has disclosed 2 trades in Biomarin Pharmaceutical Inc (BMRN) since 2014, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Lamar Smith bought $1,001 - $15,000 of Biomarin Pharmaceutical Inc (NASDAQ: BMRN) on November 14, 2014. Since that trade, BMRN is down -25.93% against the S&P 500 up +333.67%, an outperformance of -359.59%.
Across these filings, Lamar Smith has been a balanced trader of BMRN (a buy-to-sell ratio of 1.00). The most recent disclosed BMRN transaction shown was dated February 12, 2018. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Lamar Smith's BMRN trades vs the price
BMRN is down -25.93% since Lamar Smith bought on November 14, 2014, versus +333.67% for the S&P 500.
Performance since this trade
All Lamar Smith BMRN trades
Lamar Smith & BMRN trading FAQ
Is it legal for Lamar Smith to trade Biomarin Pharmaceutical Inc (BMRN) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Biomarin Pharmaceutical Inc (BMRN), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Lamar Smith buy BMRN?
Lamar Smith disclosed a purchase of $1,001 - $15,000 of Biomarin Pharmaceutical Inc (BMRN) on November 14, 2014, according to public STOCK Act filings.
How has BMRN performed since Lamar Smith's trade?
Since Lamar Smith bought BMRN on November 14, 2014, the stock is down -25.93%, versus +333.67% for the S&P 500 over the same period, an outperformance of -359.59%.
How many times has Lamar Smith traded BMRN?
Lamar Smith has disclosed 2 BMRN trades since 2014 (1 purchase and 1 sale). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BMRN trades?
Quantellect tracks every disclosed congressional trade in Biomarin Pharmaceutical Inc (BMRN) on the Biomarin Pharmaceutical Inc congressional trading page, which aggregates filings across all members of Congress.
Lamar Smith's BMRN tradesAll congressional filings for Biomarin Pharmaceutical IncLamar Smith's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.